CONTROLLING AIRFLOW WITHIN AN EXPLOSION-PROOF ENCLOSURE.

摘要

A system is described herein. The system can include an explosion-proof enclosure having an interior comprising a first region and a second region. The system can also include a heat-generating component positioned within the second region of the explosion-proof enclosure. The system can further include an air moving device positioned within the first region of the explosion-proof enclosure. The air moving device can draw a first portion of intake air from outside the explosion-proof enclosure. The air moving device can also pass the first portion of the intake air over the heat-generating component to generate first exhaust air, where the first portion of the intake air cools the heat-generating component. The air moving device can further remove the first exhaust air from the interior of the explosion-proof enclosure. A system is described herein. The system can include an explosion-proof enclosure having an interior comprising a first region and a second region. The system can also include a heat-generating component positioned within the second region of the explosion-proof enclosure. The system can further include an air moving device positioned within the first region of the explosion-proof enclosure. The air moving device can draw a first portion of intake air from outside the explosion-proof enclosure. The air moving device can also pass the first portion of the intake air over the heat-generating component to generate first exhaust air, where the first portion of the intake air cools the heat-generating component. The air moving device can further remove the first exhaust air from the interior of the explosion-proof enclosure. Methods for predicting disease statuses of cancers in subjects are provided. In some embodiments, the methods relate to determining a level of biological activity of a member of the MMP and/or the ADAM family of polypeptides in a biological sample isolated from or in the subject, wherein the determining provides a prediction of the disease status of the cancer in the subject. Also provided are methods for detecting enzyme activity of a member of the MMP and/or the ADAM family of polypeptides, peptides that include particular amino acid sequences, and methods for predicting disease status of breast cancer.